Clinical emergence of a novel extended-spectrum variant deriving from the OXY-1 β-lactamase

Mammeri, Hedi
DOI: https://doi.org/10.1007/s10096-024-04922-8
2024-08-24
European Journal of Clinical Microbiology & Infectious Diseases
Abstract:The genomic comparison of two Klebsiella michiganensis clinical isolates recovered from the same patient, one resistant to piperacillin-tazobactam and intermediate to cefotaxime, the other resistant to ceftazidime but susceptible to piperacillin-tazobactam, revealed one mutation in the bla OXY-1-24 gene accounting for a L169M substitution in the Ω loop. Cloning experiment in Escherichia coli demonstrated the contribution of this mutation to the hydrolysis spectrum extension towards ceftazidime and cefepime, whereas the resistance to piperacillin-tazobactam was reduced. To the best of our knowledge, this study shows for the first time that ceftazidime resistance can occur in vivo from OXY-1 precursor by structural alteration.
infectious diseases,microbiology
What problem does this paper attempt to address?